Schmitz Silke Salavati
Hospital for Small Animals, Royal (Dick) School of Veterinary Studies, The Roslin Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Easter Bush, Midlothian EH25 9RG, UK.
Vet Clin North Am Small Anim Pract. 2021 Jan;51(1):171-217. doi: 10.1016/j.cvsm.2020.09.011.
Probiotics/or synbiotics products for small animals do not fulfill the criteria required to qualify as a probiotic. Studies explaining modes of action are lacking. Outcome measures are inconsistent, with some trials assessing only nonspecific routine diagnostic parameters or fecal scores. Preliminary evidence shows that specific preparations are beneficial in parvovirus infections and acute hemorrhagic diarrhea syndrome in dogs and in Tritrichomonas fetus infection in cats. In dogs, inflammatory bowel disease specific probiotics can decrease clinical severity. More studies focusing on functional outcomes in dogs and cats with well-defined diseases to allow evidence-based clinical use of probiotics and synbiotics are needed.
用于小动物的益生菌/合生元产品不符合益生菌的认定标准。缺乏解释其作用方式的研究。结果衡量指标不一致,一些试验仅评估非特异性的常规诊断参数或粪便评分。初步证据表明,特定制剂对犬细小病毒感染、急性出血性腹泻综合征以及猫胎儿三毛滴虫感染有益。对犬而言,炎症性肠病特异性益生菌可减轻临床严重程度。需要开展更多针对患有明确疾病的犬猫的功能结局的研究,以便基于证据将益生菌和合生元用于临床。